CMS Ventures, the corporate venture capital arm of China Medical System, primarily focuses on investing in seed and Series A rounds for biotechnology and life sciences startups across the United Kingdom. Their investments specialize in therapeutics, diagnostics, devices, and digital health.
50% of their portfolio is in Crypto & Web3. Their most common stage is seed (56% of deals). Average disclosed round size is $64.1M (across 16 rounds with reported amounts).
Portfolio
16
Fund Size
$62.9M
Top Stage
Seed
Last 12 Mo
2
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Billy Bets | Pre-Seed | $1M | Sep 2025 |
| NNoxtua | Series B | $80.7M | Apr 2025 |
 Drop Protocol | Seed | $4M | Oct 2024 |
| AAPRO Oracle | Seed | $3M | Oct 2024 |
 Root Protocol | Seed | $10M | Jan 2024 |
 Stakes | Seed | $5.3M | May 2022 |
 GamerGains Lab, Inc. | Seed | $5.8M | Apr 2022 |
 Slope Finance | Series A | $8M | Feb 2022 |
 Figment | Series C | $110M | Dec 2021 |
 Ondo Finance | Seed | $4M | Aug 2021 |
 Avalanche | Unknown | $230M | Jun 2021 |
| AAvalanche Foundation | Growth | $230M | Jun 2021 |
| SSolana Labs | Growth | $314.1M | Jun 2021 |
 Injective Protocol | Seed | $10M | Apr 2021 |
 Vega | Seed | $5M | Mar 2021 |
| VVega Protocol | Seed | $5M | — |
Top Co-Investors
Polychain Capital4 shared
Cadenza Ventures3 shared
Coinbase Ventures3 shared
ParaFi Capital3 shared
Signum Capital3 shared
Digital Currency Group2 shared
Dragonfly2 shared
Pantera2 shared
Arrington Capital2 shared
CMT Digital2 shared
CoinFund2 shared
Global Brain1 shared
Andreessen Horowitz1 shared
Alameda Research1 shared
Blockchange Ventures1 shared
LDV Capital1 shared
Three Arrows Capital1 shared
BlockTower1 shared
Hashed1 shared
Tiger Global Management1 shared
Last updated: 16 April 2026